ADAM12 inhibitory antibodies or genetically altered tissue inhibitor of metalloproteinases 2 (TIMP2) for specifically blocking ADAM12 or recombinant ADAM12 prodomain still need to be investigated in animal models of cancer cell migration [262, 263]. Here, ADAM12 is linked to cancer.